(Q40522737)

21 September 2017

Adenovirus-based gene therapy during clevudine treatment of woodchucks chronically infected with woodchuck hepatitis virus (English)

1 reference

Woodchuck hepatitis virus

21 September 2017

0 references

1 reference

object named as

woodchuck hepatitis virus

1 reference

Yuao Zhu

1

1 reference

21 September 2017

John M Cullen

2

1 reference

21 September 2017

Carol E Aldrich

3

1 reference

21 September 2017

Jeffry Saputelli

4

1 reference

21 September 2017

Darren Miller

5

1 reference

21 September 2017

Christoph Seeger

6

1 reference

21 September 2017

William S Mason

7

1 reference

21 September 2017

Allison R Jilbert

8

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 September 2004

1 reference

21 September 2017

1 reference

21 September 2017

327

1 reference

21 September 2017

1

1 reference

21 September 2017

26-40

1 reference

Peginterferon alpha-2a (40 kDa): an advance in the treatment of hepatitis B e antigen-positive chronic hepatitis B.

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Increased hepatocyte turnover and inhibition of woodchuck hepatitis B virus replication by adefovir in vitro do not lead to reduction of the closed circular DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Viral cross talk: intracellular inactivation of the hepatitis B virus during an unrelated viral infection of the liver

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Viral Clearance Without Destruction of Infected Cells During Acute HBV Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Apoptosis and regeneration of hepatocytes during recovery from transient hepadnavirus infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Conditional replication of duck hepatitis B virus in hepatoma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

A simplified system for generating recombinant adenoviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Establishment and characterization of a diethylnitrosamine-initiated woodchuck hepatocyte cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Lamivudine therapy of WHV-infected woodchucks.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

In vivo study of the mechanism of action of antiviral agents against hepadna virus replication in the liver. Resistance of supercoiled viral DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Cytokine-sensitive replication of hepatitis B virus in immortalized mouse hepatocyte cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Antiviral activity of clevudine [L-FMAU, (1-(2-fluoro-5-methyl-beta, L-arabinofuranosyl) uracil)] against woodchuck hepatitis virus replication and gene expression in chronically infected woodchucks (Marmota monax).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

How will we use the new antiviral agents for hepatitis B?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Nuclear covalently closed circular viral genomic DNA in the liver of hepatocyte nuclear factor 1 alpha-null hepatitis B virus transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Hepatocyte turnover during resolution of a transient hepadnaviral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Mutations in the conserved woodchuck hepatitis virus polymerase FLLA and YMDD regions conferring resistance to lamivudine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Is combination therapy with lamivudine and interferon-alpha superior to monotherapy with either drug?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Low dynamic state of viral competition in a chronic avian hepadnavirus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Combination therapy with lamivudine and adenovirus causes transient suppression of chronic woodchuck hepatitis virus infections.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Kinetics of hepadnavirus loss from the liver during inhibition of viral DNA synthesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

7 January 2021

Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

7 January 2021

Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

7 January 2021

Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2004.06.017

7 January 2021

10.1016/J.VIROL.2004.06.017

Identifiers

DOI

1 reference

21 September 2017

1 reference